Literature DB >> 33189816

The role of non-coding RNA network in atherosclerosis.

Yuchan Yuan1, Ling Xu2, Zhaohong Geng3, Jingjing Liu1, Lijiao Zhang3, Yuhang Wu1, Dan He4, Peng Qu5.   

Abstract

Atherosclerosis is the primary culprit of cardiovascular and cerebrovascular diseases. Also, atherogenesis and the development of atherosclerosis involve endothelial cells, monocytes/macrophages, smooth myocytes, and others. Increasingly, studies have found that non-coding RNA (ncRNA) which can regulate apoptosis, pyroptosis, autophagy, proliferation, and monocyte migration participates in atherogenesis and progress of atherosclerosis by the above. The ncRNA networks may be essential in regulating the complicated process of atherosclerosis. Accordingly, this review delves into the regulatory roles of ncRNA, which were introduced previously. The answer above is particularly crucial to explain further the regulatory mechanism of ncRNA in cardiovascular disorders. Furthermore, we discuss the possibility and related research of ncRNAs as a biomarker and therapeutic target for the prevention, diagnosis, and treatment of atherosclerosis.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Atherosclerosis; Endothelial cells; Monocytes/macrophages; Non-coding RNAs; VSMCs

Year:  2020        PMID: 33189816     DOI: 10.1016/j.lfs.2020.118756

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  4 in total

1.  CircRNA-PTPRA Knockdown Inhibits Atherosclerosis Progression by Repressing ox-LDL-Induced Endothelial Cell Injury via Sponging of miR-671-5p.

Authors:  Xueting Luo; Xiaoli Zhou
Journal:  Biochem Genet       Date:  2022-07-11       Impact factor: 2.220

Review 2.  DNA Methylation Aberrant in Atherosclerosis.

Authors:  Yao Dai; Danian Chen; Tingting Xu
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

Review 3.  Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?

Authors:  Ana Clara Aprotosoaie; Alexandru-Dan Costache; Irina-Iuliana Costache
Journal:  Pharmaceutics       Date:  2022-03-28       Impact factor: 6.525

4.  BAG3 Alleviates Atherosclerosis by Inhibiting Endothelial-to-Mesenchymal Transition via Autophagy Activation.

Authors:  Hongtao Diao; Kaili Wu; Dingming Lan; Dongwei Wang; Jingjing Zhao; Bingying Huang; Xiaoqi Shao; Ruonan Wang; Huiling Tan; Xinyuan Tang; Meiling Yan; Yue Zhang
Journal:  Genes (Basel)       Date:  2022-07-26       Impact factor: 4.141

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.